KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Assets (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Assets for 13 consecutive years, with $97.7 million as the latest value for Q4 2025.

  • Quarterly Assets rose 149.42% to $97.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $97.7 million through Dec 2025, up 149.42% year-over-year, with the annual reading at $97.7 million for FY2025, 149.42% up from the prior year.
  • Assets hit $97.7 million in Q4 2025 for ClearPoint Neuro, up from $60.4 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $97.7 million in Q4 2025 to a low of $30.1 million in Q1 2025.
  • Historically, Assets has averaged $56.9 million across 5 years, with a median of $56.6 million in 2022.
  • Biggest five-year swings in Assets: soared 214.87% in 2021 and later crashed 43.94% in 2025.
  • Year by year, Assets stood at $65.6 million in 2021, then fell by 15.39% to $55.5 million in 2022, then dropped by 23.12% to $42.7 million in 2023, then decreased by 8.14% to $39.2 million in 2024, then skyrocketed by 149.42% to $97.7 million in 2025.
  • Business Quant data shows Assets for CLPT at $97.7 million in Q4 2025, $60.4 million in Q3 2025, and $62.9 million in Q2 2025.